Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group study

C. Cripps, E. A. Eisenhauer, Jacques Jolivet et al.|Annals of Oncology|1999

Cited by 100